Neurocrine Biosciences, Inc. (NBIX)

Last Closing Price: 123.66 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Neurocrine Biosciences, Inc. (NBIX) had Net Income of $7.90M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$572.60M
Net Income
$7.90M
$9.20M
$563.40M
$549.00M
$23.60M
$-8.90M
$14.70M
$45.30M
$7.90M
$7.90M
$7.90M
$52.66M
$23.60M
$31.20M
99.70M
102.50M
$0.08
$0.08
Balance Sheet Financials
$1.64B
$87.00M
$2.05B
$3.69B
$522.90M
--
$629.10M
$1.15B
$2.54B
$2.50B
$2.54B
99.00M
Cash Flow Statement Financials
$64.80M
$14.20M
$-117.90M
$241.00M
$202.10M
$-38.90M
$52.80M
--
--
Fundamental Metrics & Ratios
3.13
--
--
--
--
98.39%
4.12%
4.12%
--
2.57%
1.38%
$54.10M
--
--
--
0.16
0.16
1.11
81.10
0.31%
0.32%
0.21%
0.31%
$25.61
$0.53
$0.63